When Eczema Turns Out Cancerous: The Mystery of CTCL

Biomarkers don't itch - patients do.

In this episode we will summarize some of the contents of the recent USCLC meeting at the American Academy of Dermatology meeting in Denver 2026 : Discussing role of biomarkers in diagnosis and prognosis,  lymph node assessment using volume and kinetic modeling and use of AI to better understand MF patients' needs.

When Eczema Turns Out Cancerous: The Mystery of CTCL

In this episode, we’re diving into the complex intersection of chronic skin inflammation and a rare form of skin cancer—cutaneous T-cell lymphoma (CTCL). Join dermatologist Dr. Shamir Geller as he takes us through the challenges of diagnosing CTCL in patients who’ve been living with long-term inflammatory skin conditions like eczema and atopic dermatitis. How can you tell when a chronic skin rash evolves from mere inflammation into something far more serious? And what happens when treatments designed for inflammation might unmask a hidden lymphoma? Dr. Geller explains the molecular and genetic clues that can make all the difference, as well as the importance of vigilance and early diagnosis in this delicate balancing act. Whether you're a clinician or simply curious, this conversation will leave you with a new perspective on how skin disease can evolve—and why it’s crucial to listen to the body when it sends out subtle signals. Tune in for a fascinating, thought-provoking episode.

Skin Cancer’s Hidden Truths Across Skin Color

Why does a rare skin cancer look completely different depending on the color of your skin? And why, even when receiving the same medical care, do survival rates differ so drastically in different populations? In this eye-opening episode, join Dr. Shamir Geller, as he pulls back the curtain on The Great Imposter: Mycosis Fungoides and Sézary Syndrome. This isn't just a medical lecture—it’s a deep dive into the intersection of biology, race, and equitythat challenges what we know about skin lymphoma and skin color.